Skip to content

Exploring the Clinical Application of a Novel Elbow Joint Torque Measuring Tool Based on Surface Electromyography Features

Exploring the Clinical Application of a Novel Elbow Joint Torque Measuring Tool Based on Surface Electromyography Features

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097117
Enrollment
Unknown
Registered
2025-02-12
Start date
2024-04-20
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

the experimental group: the novel Elbow Joint Torque Measuring Tool
the control group: the experimental group used the novel EJTMT (patent number: 202211075457. X). The muscle strength and AROM were measured in the control group using a hand-held muscle strength teste

Sponsors

the First affiliated hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 68 Years

Inclusion criteria

Inclusion criteria: 1. All patients met the diagnostic criteria of stroke formulated by the Fourth Cerebrovascular Disease Conference, were diagnosed with stroke by head CT or MRI, and had unilateral hemiplegia. 2. The age range of each patient was from 30 to 65. 3. Every patient had an MMSE score of at least 22. 4. The affected upper limb's Brunnstrom stage was >=?, its key muscle strength was > grade 1, and its Modified Ashworth Score was < grade 3. 5. Every patient was able to flex and extend their elbows on their own, or with minimal assistance, and stay stable for at least six seconds. 6. All patients with stable vital signs, clear consciousness, could cooperate to complete the assessment. 7. All patients and their families gave informed consent for this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with brain stem and thalamus lesions. 2. Patients with serious cardiac disease, hypertension, acute sickness, or unstable medical conditions. 3. Patients with cardiac pacemakers or intracranial metallic implants. 4. Patients with a previous history of epilepsy or a family history of epilepsy. 5. Patients with severe visual impairment, auditory impairment, balance dysfunction, cognitive impairment, or speech disorders. 6. The upper limbs involvement in peripheral neuropathic diseases due to diabetes, alcoholism, drug intoxication, and other causes. 7. The upper limbs were complicated with diseases that could cause aberrant electromyography signals, such as demyelinating disorders of the central nervous system.

Design outcomes

Primary

MeasureTime frame
Integral electrical values;root-mean-square value;MEP cortical latency;MEP cortical amplitude;joint range of motion;muscular strength;

Countries

China

Contacts

Public ContactHemu Chen

The First Affiliated Hospital of Anhui Medical University

chenhemu123@126.com+86 138 5518 8106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026